News – Page 8 – Serendipity Innovations

2017-02-08

Episurf Medical to exhibit at the AAOS 2017 in San Diego, California

2017-01-31

Analyst coverage on Xbrane Biopharma

2017-01-19

Episurf Medical AB to present at Aktiekvällen, held in Stockholm on January 23

2017-01-18

Episurf Medical AB is expanding its Clinical Advisory Board

2017-01-12

Vote for OrganoClick – Sweden’s National Champion in The European Business Awards

2016-12-30

OrganoClick finalises acquisition of Biokleen Miljökemi

2016-12-19

Resolutions at the OrganoClick Extraordinary General Meeting

2016-12-13

Episurf Medical featured in the magazine Runner’s World

2016-12-09

Serendipity-grundarna Saeid Esmaeilzadeh och Ashkan Pouya i Dagens Nyheter

2016-12-07

OrganoClick® – one of Sweden’s fastest growing technology companies

2016-12-03

Serendipity-grundarna Saeid Esmaeilzadeh och Ashkan Pouya på TV4 Nyhetsmorgon

2016-12-02

OrganoClick® is one of the selected businesses to participate at the SwitchMed event in Tunisia

2016-12-01

Episurf Medical’s 50th Episealer® Femoral Twin implant demonstrates rapid clinical adoption

2016-11-30

Change in number of shares and votes in Episurf Medical

2016-11-29

Learn how an Episurf implant is made for you

2016-11-28

Episurf Medical achieves milestone of 150th implant

2016-11-23

Episurf patient Nicklas Rudsten and orthopaedic surgeon Leif Ryd featured in Aftonbladet

2016-11-22

Xbrane Biopharma to present at Stora Aktiedagen on November 28 in Stockholm

2016-11-21

Xbrane Biopharma AB (publ) releases interim report for the period July – September 2016

2016-11-21

Episurf Medical AB to present at Stora Aktiedagen, held in Stockholm on November 28

2016-11-17

Interview with Episurf Medical CEO Rosemary Cunningham Thomas on Analysguiden

2016-11-17

Serendipity-grundarna Ashkan Pouya och Saeid Esmaeilzadeh intervjuas i SvD

2016-11-14

Serendipity-grundarna Ashkan Pouya och Saeid Esmaeilzadeh intervjus i tidningen Chef

2016-11-14

OrganoClick participates in a Vinnova project to phase out PFAS

2016-11-11

OrganoClick AB (publ) publish interim report for the third quarter 2016

2016-11-11

OrganoClick has entered into an agreement to acquire BIOkleen Miljökemi AB

2016-11-09

Episurf Medical AB to present at Stora Aktiedagen, held in Gothenburg on November 14

2016-11-08

Serendipity-grundarna Ashkan Pouya och Saeid Esmaeilzadeh intervjuas i tidningen Driva Eget

2016-11-04

Episurf Medical Interim report 1 July – 30 September, 2016

2016-11-01

Xbrane signs term-sheet for distribution of Spherotide in China generating approx. SEK 70 M in revenue until market approval and expected sales of SEK 350 M annually for Xbrane and the Chinese partner

page 8 of 10